These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 136521)

  • 1. Assessment of diabetogenic drug activity in the rat: diphenylhydantoin.
    Mackerer CR; Saunders RN; Haettinger JR
    J Toxicol Environ Health; 1976 Sep; 2(1):139-51. PubMed ID: 136521
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of diabetogenic drug activity in the rat: 5,5-diphenyl-2-thiohydantoin.
    Mackerer CR; Saunders RN; Haettinger JR; Mehlman MA
    J Toxicol Environ Health; 1977 May; 2(5):1041-51. PubMed ID: 140944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by diphenylhydantoin of the diabetogenic action of streptozotocin.
    Schimmel RJ; Graham D
    Horm Metab Res; 1974 Nov; 6(6):475-7. PubMed ID: 4281411
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptozotocin-diabetes in the Chinese hamster. Long-term effects on the light microscopic structure of the pancreatic islet tissue, liver and kidney.
    Wilander E
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):767-76. PubMed ID: 4280870
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of 1,3-butanediol on blood glucose concentration and pancreatic insulin content of streptozotocin-diabetic rats.
    Mackerer CR; Saunders RN; Haettinger JR; Mehlman MA
    Fed Proc; 1975 Nov; 34(12):2191-6. PubMed ID: 126871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetogenic activity of deoxy-2-(((ethylnitrosoamino) carbonyl)amino)-D-glucopyranose.
    Anderson T; McMenamin M; Schein PS
    Biochem Pharmacol; 1975 Mar; 24(6):746-7. PubMed ID: 164873
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth.
    Movassat J; Portha B
    Diabetologia; 1999 Sep; 42(9):1098-106. PubMed ID: 10447522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on exocrine and endocrine rat pancreatic functions of bovine lung trypsin inhibitor administered perorally.
    Arnesjö B; Ihse I; Lundquist I; Qvist I
    Scand J Gastroenterol; 1973; 8(6):545-54. PubMed ID: 4589375
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood glucose and the histology of the pancreatic islets of Heteropneustes fossilis (Bl.) treated with streptozotocin.
    Khanna SS; Rekhari K
    Acta Anat (Basel); 1973; 85(1):63-8. PubMed ID: 4268273
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative morphological studies on the diabetogenic effect of streptozotocin in rats, Chinese hamsters, guinea pigs and rabbits].
    Richter KD; Loge O; Losert W
    Arzneimittelforschung; 1971 Nov; 21(11):1654-6. PubMed ID: 4258515
    [No Abstract]   [Full Text] [Related]  

  • 12. [Streptozotocin].
    Rudas B
    Arzneimittelforschung; 1972 May; 22(5):830-61. PubMed ID: 4340253
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K; Mizuno A; Sano T; Noma Y; Shima K
    Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of streptozotocin on insulin and glucagon responses of rat islets.
    Katsilambros N; Rahman YA; Hinz M; Fussgänger R; Schröder KE; Straub K; Pfeiffer EF
    Horm Metab Res; 1970 Sep; 2(5):268-70. PubMed ID: 4258677
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs producing diabetes through damage of the insulin secreting cells.
    Rerup CC
    Pharmacol Rev; 1970 Dec; 22(4):485-518. PubMed ID: 4921840
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
    Junod A; Lambert AE; Stauffacher W; Renold AE
    J Clin Invest; 1969 Nov; 48(11):2129-39. PubMed ID: 4241908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative biochemical study on the diabetogenic effect of streptozotocin in mice, rats, Chinese hamsters and guinea pigs].
    Losert W; Rilke A; Loge O; Richter KD
    Arzneimittelforschung; 1971 Nov; 21(11):1643-53. PubMed ID: 4334222
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats.
    West E; Simon OR; Morrison EY
    West Indian Med J; 1996 Jun; 45(2):60-2. PubMed ID: 8772396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic implantation of pancreatic endocrine islets. Its efficacy in the treatment of experimental diabetes].
    Grenier JF; Haffen K; Kedinger M; Dauchel J; Eloy R
    Chirurgie; 1976 Mar; 102(4):256-66. PubMed ID: 136335
    [No Abstract]   [Full Text] [Related]  

  • 20. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.